New Treatment For Multiple Sclerosis Shows Promise In Lab Tests

  • Share
    Share Video

  • Add
  • More
    Report this video as:
0 0
You have already voted for this video.
Lab tests of Bowman-Birk inhibitor (BBI), a soy-derived protease inhibitor, show promise in the treatment o...
Lab tests of Bowman-Birk inhibitor (BBI), a soy-derived protease inhibitor, show promise in the treatment of Multiple Sclerosis.
Related